Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Stenberg cells of Hodgkin lymphoma

Blood

Volumn 99, Issue 2, 2002, Pages 618-626

  Skinnider, Brian F ^a,b,c,d,e   Elia, Andrew J ^a,b,c,d,e   Gascoyne, Randy D ^a,b,c,d,e   Patterson, Bruce ^a,b,c,d,e   Trumper, Lorenz ^a,b,c,d,e   Kapp, Ursula ^a,b,c,d,e   Mak, Tak W ^a,b,c,d,e  

^a AMGEN INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

STAT6 PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; AUTOCRINE EFFECT; CYTOKINE RELEASE; DIMERIZATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; REED STERNBERG CELL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0037079728     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.2.618     Document Type: Article

References (41)

1. Hodgkin's disease: Classification and differential diagnosis
2. Cytokines and cytokine receptors in Hodgkin's disease
3. Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells
4. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma
5. Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease
6. Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease
7. The role of STATs in transcriptional control and their impact on cellular function
8. JAKs and STATs: Biological implications
9. Stat3 activation is required for cellular transformation by v-src
10. Distinct tumorigenic potential of abl and raf in B cell neoplasia: Abl activates the IL-6 signaling pathway
11. The biology of Stat4 and Stat6
12. STATs in oncogenesis
13. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells
14. Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients
15. Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease
16. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
17. Differential T cell costimulatory requirements in CD28-deficient mice
18. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins
19. Essential role of Stat6 in IL-4 signaling
20. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene
21. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice
22. Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease
23. Interleukin-4 may contribute to the abundant T-cell reaction and paucity of neoplastic B cells in T-cell-rich B-cell lymphoma
24. Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease
25. Interleukin-9 expression in human malignant lymphomas: Unique association with Hodgkin's disease and large cell anaplastic lymphoma
26. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines
27. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs
28. Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia
29. Stat3 as an oncogene
30. STAT5 activation by BCR-Abl contributes to transformation of K562 leukemia cells
31. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis
32. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
33. L through Stat5 in erythropoietin-dependent progenitor cell lines
34. Proliferation of adult T cell leukemia/lymphoma cell is associated with the constitutive activation of JAK/STAT proteins
35. BCR/ABL induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members
36. Targeted disruption of Stat6 DNA binding activity by an oligonucleotide decoy blocks IL-4-driven TH2 cell response
37. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells
38. Kip1
39. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13
40. Differential expression of chemokines in Th1 and Th2 cells is dependent on Stat6 but not Stat4
41. Differential chemokine expression in tissues involved by Hodgkin's disease: Direct correlation of eotaxin expression and tissue eosinophilia